KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Q3 2025 Earnings Call Transcript November 11, 2025
Operator: Good day, and thank you for standing by. Welcome to KalVista Pharmaceuticals’ 2025 Third Quarter Financial Update and Operating Results Conference Call. [Operator Instructions] Please note that today’s conference is being recorded. I will now hand the conference over to your first speaker, Ryan Baker, Head of Investor Relations. Please go ahead.
Ryan Baker: Thank you, operator. Good...
